Science 37 Holdings, Inc. financial data

Industry
Services-Commercial Physical & Biological Research
Location
800 Park Offices Drive, Suite 3606, Research Triangle Park, NC
State of incorporation
DE
Fiscal year end
December 31
Former names
Lifesci Acquisition II Corp. (to 10/6/2021)
Latest financial report
10-Q - Q3 2023 - Nov 7, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 504 % -22.2%
Debt-to-equity 34.9 % -16.3%
Return On Equity -172 % -448%
Return On Assets -128 % -475%
Operating Margin -215 % -36.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 119M shares +2.34%
Common Stock, Shares, Outstanding 119M shares +2.18%
Entity Public Float 140M USD +70.8%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 118M shares +1.49%
Weighted Average Number of Shares Outstanding, Diluted 118M shares +1.49%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 60.3M USD -19.2%
Costs and Expenses 190M USD -1.02%
Operating Income (Loss) -130M USD -10.6%
Nonoperating Income (Expense) 4.82M USD -92.9%
Income Tax Expense (Benefit) -88K USD
Net Income (Loss) Attributable to Parent -125M USD -151%
Earnings Per Share, Basic -1.08 USD/shares -178%
Earnings Per Share, Diluted -1.04 USD/shares -178%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 56.4M USD -56.7%
Other Assets, Current 370K USD
Assets, Current 75.5M USD -48.2%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 186K USD +21.6%
Assets 75.7M USD -60%
Accounts Payable, Current 6.67M USD +0.86%
Employee-related Liabilities, Current 4.25M USD -41.7%
Accrued Liabilities, Current 8.36M USD -29.7%
Contract with Customer, Liability, Current 3.08M USD -33%
Liabilities, Current 18.1M USD -21.6%
Contract with Customer, Liability, Noncurrent 4.71M USD +13%
Operating Lease, Liability, Noncurrent 47K USD -94.6%
Other Liabilities, Noncurrent 60K USD -95.7%
Liabilities 24M USD -22.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 207K USD +36.2%
Retained Earnings (Accumulated Deficit) -311M USD -66.8%
Stockholders' Equity Attributable to Parent 51.7M USD -67.4%
Liabilities and Equity 75.7M USD -60%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.6M USD +29.9%
Net Cash Provided by (Used in) Financing Activities 87K USD -23.7%
Net Cash Provided by (Used in) Investing Activities -5.95M USD +17.2%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 119M shares +2.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.4M USD +27.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 56.4M USD -56.7%
Deferred Tax Assets, Valuation Allowance 76.1M USD +91.2%
Deferred Tax Assets, Gross 76.2M USD +65%
Operating Lease, Liability 581K USD -60.9%
Payments to Acquire Property, Plant, and Equipment 11K USD -92.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -125M USD +40.5%
Lessee, Operating Lease, Liability, to be Paid 603K USD -62.6%
Property, Plant and Equipment, Gross 0 USD -100%
Operating Lease, Liability, Current 534K USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 138K USD -77%
Lessee, Operating Lease, Liability, to be Paid, Year One 465K USD -31%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22K USD -82.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12K USD -91.3%
Deferred Tax Assets, Operating Loss Carryforwards 62.9M USD +45.9%
Unrecognized Tax Benefits 240K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12K USD -91.3%
Additional Paid in Capital 363M USD +5.15%
Depreciation, Depletion and Amortization 5.89M USD -61.2%
Deferred Tax Assets, Net of Valuation Allowance 91K USD -98.6%
Share-based Payment Arrangement, Expense 17.4M USD -32.8%